About Obstetric Cholestasis

Overview

Intrahepatic cholestasis of pregnancy (ICP), also known as obstetric cholestasis, is a liver disorder that specifically occurs during pregnancy. It’s characterized by impaired release of bile (a digestive fluid) from liver cells. This leads to a buildup of bile in the liver, which impairs liver function. The condition typically becomes apparent in the third trimester of pregnancy and gets better after delivery. However, it can reoccur (come back) in subsequent pregnancies.

Intrahepatic cholestasis of pregnancy is often accompanied by severe itching (pruritus), starting from the palms of the hands and soles of the feet and spreading to other parts of the body. In some cases, affected individuals may also develop yellowing of the skin and eyes (jaundice). It has been observed that women with this condition have a higher risk of developing gallstones later in life. Additionally, obstetric cholestasis can pose risks to the unborn baby, including premature delivery and stillbirth. The exact cause of this condition is not fully understood, although genetic changes in certain genes have been found to play a role in some cases.

Causes and Risk Factors

Non-modifiable risk factors for obstetric cholestasis are factors that can’t be changed. These include:

  • Genetic susceptibility: Certain genetic factors can make some women more prone to developing obstetric cholestasis. Mutations in genes related to hepatobiliary transport or nuclear regulators may play a role in the occurrence and severity of obstetric cholestasis.
  • Previous history of obstetric cholestasis: Women who have previously experienced obstetric cholestasis in a previous pregnancy have an increased risk of developing it again in subsequent pregnancies.

Modifiable risk factors for obstetric cholestasis are factors that can be influenced or changed. These include:

  • Hormonal changes: The hormonal changes that occur during pregnancy, particularly the increase in estrogen and progesterone levels, can affect the normal functioning of the liver and bile ducts, leading to the development of obstetric cholestasis.
  • Liver function: If a woman already has an underlying liver condition or impaired liver function, she may be at a higher risk for developing obstetric cholestasis during pregnancy.

It's important to note that while these risk factors can increase the likelihood of developing obstetric cholestasis, not all women with these risk factors will develop the condition, and some women without any known risk factors may still develop it. If you have any concerns about obstetric cholestasis, it's best to speak with your healthcare provider who can provide personalized advice and guidance based on your specific situation.

Symptoms

The most common early symptom of obstetric cholestasis is itching without a rash. This itching typically occurs in the second or third trimester of pregnancy, usually after 30 weeks. It commonly affects the palms of the hands and soles of the feet, but it can also affect other parts of the body.

As the condition progresses or becomes more severe, there may be additional symptoms that can occur. These symptoms may include:

  • Jaundice: In some cases, mild jaundice may develop within 4 weeks of the appearance of itching. Jaundice causes a yellowing of the skin and eyes.
  • Pale stools: Some individuals with intrahepatic cholestasis of pregnancy may experience pale or clay-colored stools. This can be a result of impaired bile flow.
  • Dark urine: Dark urine can also be a symptom of intrahepatic cholestasis of pregnancy. It is caused by the buildup of bile acids in the bloodstream.
  • Abdominal (stomach) pain: Abdominal pain may occur in some cases. It is important to consult with a healthcare professional if you experience abdominal pain during pregnancy.
  • Nausea: Nausea is another symptom that may accompany intrahepatic cholestasis of pregnancy.

It’s important to note that not all individuals with this condition will experience all of these symptoms. The severity and progression of symptoms can vary from person to person.

If you are pregnant and experiencing itching without a rash or any other concerning symptoms, it’s recommended to see your doctor for an evaluation. They can provide an accurate diagnosis and appropriate management for your specific situation.

Diagnosis

To diagnose obstetric cholestasis, healthcare providers may perform the following examinations, tests, and procedures:

  • Physical Exam: During a physical exam, the healthcare provider will look for physical signs of a medical problem, such as pain, swelling, or the presence of masses within the body.
  • Lab Tests: Healthcare providers may recommend specific lab tests to help diagnose the condition. These tests can include:
    • Blood Draw: A blood sample is taken to check for changes in genes, chromosomes, or proteins. This can confirm or rule out a suspected genetic disease.
    • Total Serum Bile Acid Test: This blood test measures the level of bile acids in the blood. Elevated levels of bile acids can indicate obstetric cholestasis.
    • Liver Function Tests: Additional blood tests may be ordered to assess how well the liver is functioning. These tests include alanine aminotransferase, bilirubin, and aspartate aminotransferase tests.
  • Imaging Studies: Depending on the symptoms and part of the body being examined, healthcare providers may recommend imaging studies such as an ultrasound scan. These scans can be used to look for abnormalities in the liver and monitor fetal health and development during pregnancy.
  • Genetic Testing: Since obstetric cholestasis is considered a genetic disease, genetic testing may be recommended by healthcare providers. Genetic tests use samples of blood, saliva, or other tissues to identify changes in genes, chromosomes, or proteins.

To determine the stage or severity of obstetric cholestasis, additional examinations, tests, and procedures may be performed:

  • Non-stress tests: Regular non-stress tests may be recommended to check how often the fetus moves within a given period and measure their heartbeat in relation to body movements.
  • More frequent ultrasound scans: Healthcare providers may recommend more frequent ultrasound scans to monitor fetal health and development on a regular basis.

It's important to follow up with your healthcare provider if any symptoms worsen or change after your physical exam. They will provide guidance based on your specific situation and recommend appropriate examinations, tests, and procedures to diagnose and manage obstetric cholestasis.

Treatment Options

The goals of treatment for obstetric cholestasis are to alleviate symptoms and reduce the risk of harm for both the mother and the baby.

Medications for obstetric cholestasis include:

  • Ursodeoxycholic acid (UDCA) is the most commonly prescribed medication for obstetric cholestasis. UDCA works by reducing the levels of bile acids in the blood, which helps alleviate symptoms such as itching (pruritus). It is usually taken in a dose of 15 mg/kg per day, and most individuals respond well to this treatment.
  • S-adenosyl-methionine: This is a supplement that may be beneficial for individuals who don’t respond to other types of treatment. It can be used in combination with UDCA to further improve symptoms.
  • Cholestyramine: Another therapeutic option is cholestyramine, which is given in a dose of 2 to 4 grams per day and gradually increased (up to a maximum of 16 grams per day). Cholestyramine works by binding to bile acids in the intestine, preventing their reabsorption into the bloodstream. However, it can cause constipation and may interfere with the absorption of fat-soluble vitamins like vitamin K when taken in higher doses.

Health behavior changes for obstetric cholestasis work alongside medication and therapeutic procedures. certain health behavior changes may help manage obstetric cholestasis. These include:

  • Avoiding triggers: It is important to identify any triggers that worsen symptoms and try to avoid them. Triggers can vary from person to person but may include hot showers, tight clothing, or certain foods.
  • Monitoring fetal movements: Regularly monitoring the baby's movements can help detect any changes or potential complications. If there are concerns about decreased fetal movements, it's important to seek medical attention promptly.
  • Premature delivery consideration: In severe cases where other treatments have failed or there is an increased risk to the baby's health, premature delivery may be considered as a last resort. This decision would be made by healthcare professionals based on individual circumstances.

It's worth noting that while UDCA is widely used as a treatment for obstetric cholestasis, there has been some controversy regarding its effectiveness in improving adverse pregnancy outcomes. Ongoing research aims to provide more evidence on its benefits in managing this condition.

Remember, always consult with your healthcare provider for personalized advice and guidance regarding your specific situation.

Progression or Complications

The natural progression of obstetric cholestasis involves the symptoms typically resolving postpartum. However, it is important to note that the recurrence rate of obstetric cholestasis is high. This means that patients may experience the disease if they become pregnant again or take contraceptive drugs.

Complications commonly associated with obstetric cholestasis include:

  • Increased risk of premature delivery: Compression of the unborn baby caused by obstetric cholestasis can lead to premature delivery, which in turn can result in neonatal asphyxia (lack of oxygen) or even death.
  • Meconium-stained amniotic fluid: This refers to the presence of meconium (the baby's first stool) in the amniotic fluid. It is more likely to occur in pregnancies affected by obstetric cholestasis.
  • Neonatal unit admission: Babies born to mothers with obstetric cholestasis have an increased likelihood of being admitted to the neonatal unit for monitoring and care.
  • Increased risk of stillbirth: Studies have shown that the risk of stillbirth is increased for women with peak serum bile acid concentrations of 100 mol/L or higher.

It's important to note that treatment for obstetric cholestasis aims to alleviate symptoms and reduce complications. Your doctor will be able to provide personalized advice and determine the best course of treatment for your specific situation.